Surfactant protein D (SP-D) is an innate immune effector that contributes to antimicrobial host defense and immune regulation. Interactions of SP-D with microorganisms and organic antigens involve binding of glycoconjugates to the C-type lectin carbohydrate recognition domain (CRD).
Surfactant Protein D (SP-D)2 is a collagenous C-type lectin (collectin) that contributes to antimicrobial host defense and immune regulation in the lung and certain extrapulmonary tissues (1-4). Like many other effectors of innate immunity, SP-D is a pattern recognition molecule with a variety of potential ligands, including microorganisms, organic particulate antigens, and apoptotic cells. However, there is also evidence that SP-D contributes to pulmonary surfactant homeostasis, in part by regulating the organization and epithelial uptake of surfactant lipids (5).SP-D is a member of a family of collectins, or collagenous C-type lectins (6). In mammals, this family also includes surfactant protein A (SP-A) and serum mannose binding lectin. Like most other collectins, SP-D is assembled as multimeric complexes of trimeric subunits, or as trimers (7). Each trimer includes an N-terminal cross-linking and collagen domain; a trimeric neck domain; and a C-terminal trimeric array of C-type carbohydrate recognition domains (CRDs).Crystallographic studies of trimeric human SP-D neckϩCRD domains have shown that maltose, a preferred saccharide ligand, binds to calcium via the vicinal 3-and 4-OH groups of the non-reducing glucose, previously designated calcium ion 1 and glucose 1 (Glc1), respectively (8). These interactions are further stabilized by hydrogen bonding of Glc1 to amino acid side chains that also coordinate with calcium ion 1.The present studies were prompted by the initial observation that p-nitrophenyl-␣-D-maltoside (p-NP-maltoside) is a potent inhibitor of SP-D binding to mannan. We hypothesized that there were interactions of the aromatic substituent with a hydrophobic or aromatic group in proximity to calcium ion 1. Preliminary modeling focused our attention on phenylalanine 335 (Phe-335) (Fig. 1A). To test our hypothesis, we used a functional, trimeric neckϩCRD (NCRD) fusion protein containing the neckϩCRD domains of human SP-D (Fig. 1, B-D) (9) and introduced site-directed substitutions at position 335. We also examined the crystal structures of purified human trimeric neckϩCRD complexed with the p-nitrophenyl-maltoside and maltotriose.